Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors
Beamion PANTUMOR-1:zongertinib治疗HER2过表达/扩增或HER2突变实体瘤的II期试验的理论依据和设计
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2637740
Schram, Alison M; Park, John J; Italiano, Antoine; Kitano, Shigehisa; Guo, Ye; Li, Jin; Bedard, Philippe L; van Marcke, Cedric; Ko, Ryo; Lunger, Lukas; Klotz, Daniel M; Hussain, Jo; Maier, Daniela; Erzen, Damijan; Planchard, David; Prenen, Hans; Clay, Timothy D; Park, Joon O; Kim, Hyung-Don; Hernando-Calvo, Alberto; Maruki, Yuta; Ponz-Sarvise, Mariano; Dumbrava, Ecaterina